Use of proteins as disease markers through a proteomic approach.
Currently, HIV+ individuals are compared with HIV+ intravenous drug users(IDUs) and HIV- persons to identify proteins involved in the infection and the effects of drug abuse in the protein expression patterns.
Effect of stress on the immune system of IDU's
The Biomedical Proteomic Facility at Universidad Central del Caribe (UCC)
The mission of the facility is to accelerate discovery by giving UCC investigators access to cutting edge technologies in Proteomics and Mass Spectrometry. The facility stimulates the use of 2D gels and protein analysis, via the software PD-Quest, by the faculty. The aim is to provide separation and mass spectrometry techniques for the quantitative analysis of the proteome. One major objective is to identify disease and other relevant biological markers.
Contact Information
Dr. Nawal Boukli
nboukli@uccaribe.edu